Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,381 | 9,332 | 23,973 | 8,441 | 6,973 |
| Receivables | 12,078 | 12,363 | 13,306 | 14,138 | 13,050 |
| Inventories | 34,234 | 35,398 | 35,290 | 34,004 | 38,167 |
| Other current assets | 6,739 | 7,125 | 376 | 369 | 388 |
| TOTAL | $62,432 | $64,218 | $80,572 | $66,718 | $64,198 |
| Non-Current Assets | |||||
| PPE Net | 507 | 573 | 689 | 712 | 731 |
| Intangibles | 77,207 | 79,760 | 81,598 | 69,285 | 71,623 |
| Other Non-Current Assets | 9,295 | 9,242 | 8,979 | 9,263 | 8,815 |
| TOTAL | $87,009 | $89,575 | $91,266 | $79,260 | $81,169 |
| Total Assets | $149,441 | $153,793 | $171,838 | $145,978 | $145,367 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,949 | 21,736 | 36,980 | 17,748 | 17,759 |
| Accounts payable and accrued liabilities | 37,687 | 39,691 | 5,730 | 39,751 | 37,117 |
| Accrued Expenses | N/A | N/A | 29,742 | N/A | N/A |
| Other current liabilities | N/A | N/A | 125 | 2,649 | 2,674 |
| TOTAL | $74,944 | $78,892 | $97,310 | $66,350 | $63,447 |
| Non-Current Liabilities | |||||
| Long Term Debt | 118 | 159 | 198 | 22,165 | 25,215 |
| Other Non-Current Liabilities | 21,961 | 21,781 | 22,187 | 24,362 | 23,964 |
| TOTAL | $22,079 | $21,940 | $22,385 | $46,527 | $49,179 |
| Total Liabilities | $97,023 | $100,832 | $119,695 | $112,877 | $112,626 |
| Shareholders' Equity | |||||
| Common Shares | 96,441 | 96,098 | 96,098 | 76,794 | 76,721 |
| Retained earnings | -61,794 | -61,479 | -61,995 | -61,442 | -62,175 |
| Other shareholders' equity | 6,058 | 6,164 | 6,029 | 5,853 | 6,233 |
| TOTAL | $52,418 | $52,961 | $52,143 | $33,101 | $32,741 |
| Total Liabilities And Equity | $149,441 | $153,793 | $171,838 | $145,978 | $145,367 |